Journal
Translational Stroke Research
Publication Date
12-1-2023
Volume
14
Issue
6
First Page
941
Last Page
954
Document Type
Open Access Publication
DOI
10.1007/s12975-022-01089-2
Rights and Permissions
Biose, I.J., Rutkai, I., Clossen, B. et al. Recombinant Human Perlecan DV and Its LG3 Subdomain Are Neuroprotective and Acutely Functionally Restorative in Severe Experimental Ischemic Stroke. Transl. Stroke Res. 14, 941–954 (2023). https://doi.org/10.1007/s12975-022-01089-2 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Biose, Ifechukwude Joachim; Rutkai, Ibolya; Clossen, Bryan; Gage, Gary; Schechtman, Kenneth; Adkisson, H Davis 4th; and Bix, Gregory J, "Recombinant human perlecan DV and its LG3 subdomain are neuroprotective and acutely functionally restorative in severe experimental ischemic stroke." Translational Stroke Research. 14, 6. 941 - 954. (2023).
https://digitalcommons.wustl.edu/oa_4/3333
Department
ICTS (Institute of Clinical and Translational Sciences)
